This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...